SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany
· Delayed Price · Currency is EUR 13.74
-0.24 (-1.72%)
At close: Mar 9, 2026
ETR:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 240.19M EUR in the quarter ending December 31, 2025, with 3.81% growth. This brings the company's revenue in the last twelve months to 995.03M, up 4.06% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth.
Revenue (ttm)
995.03M
Revenue Growth
+4.06%
P/S Ratio
2.12
Revenue / Employee
206.05K
Employees
4,829
Market Cap
2.11B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.10B |
| Siemens Healthineers AG | 23.30B |
| Bayer Aktiengesellschaft | 45.58B |
| Fresenius SE & Co. KGaA | 22.45B |
| Ottobock SE & Co. KGaA | 1.66B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
| Dermapharm Holding SE | 1.17B |
SCHOTT Pharma AG & Co. KGaA News
- 25 days ago - EQS-DD: SCHOTT Pharma AG & Co. KGaA: Dr. Torsten Derr, buy - Wallstreet:Online